Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 3/2012

01-03-2012 | Letter to the Editor

Shall we use endoscopic submucosal dissection for every gastric neoplasia?

Authors: László Czakó, Viktória Terzin, Tibor Szalóki

Published in: Journal of Gastroenterology | Issue 3/2012

Login to get access

Excerpt

We read with great interest the article by Kato et al. [1] validating the use of endoscopic submucosal dissection (ESD) for total incisional biopsy in gastric noninvasive neoplasia (NIN) (adenoma with low- or high-grade dysplasia, categories 3 and 4.1 according to the Vienna classification) diagnosed by endoscopic forceps biopsy. ESD revealed adenocarcinoma in 44% of the NIN cases. The largest diameter of the NIN lesions treated with ESD in the study varied between 2 and 55 mm. The rate of complications was reasonably low, and it was concluded that ESD may be a therapeutic option for gastric NIN. …
Literature
1.
Kato M, Nishida T, Tsutsui S, Komori M, Michida T, Yamamoto K, et al. Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia: a multicenter study by Osaka University ESD Study Group. J Gastroenterol. 2011;46(3):325–31.PubMedCrossRef
2.
3.
Park YM, Cho E, Kang HY, Kim JM. The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis. Surg Endosc. 2011;25(8):2666–77.
4.
Nakamoto S, Sakai Y, Kasanuki J, Kondo F, Ooka Y, Kato K, et al. Indications for the use of endoscopic mucosal resection for early gastric cancer in Japan: a comparative study with endoscopic submucosal dissection. Endoscopy. 2009;41(9):746–50.PubMedCrossRef
5.
Min BH, Lee JH, Kim JJ, Shim SG, Chang DK, Kim YH, et al. Clinical outcomes of endoscopic submucosal dissection (ESD) for treating early gastric cancer: comparison with endoscopic mucosal resection after circumferential precutting (EMR-P). Dig Liver Dis. 2009;41(3):201–9.PubMedCrossRef
Metadata
Title
Shall we use endoscopic submucosal dissection for every gastric neoplasia?
Authors
László Czakó
Viktória Terzin
Tibor Szalóki
Publication date
01-03-2012
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 3/2012
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-011-0525-4

Other articles of this Issue 3/2012

Journal of Gastroenterology 3/2012 Go to the issue

Review

Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded

Original Article—Alimentary Tract

The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons

Original Article—Liver, Pancreas, and Biliary Tract

Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients

Original Article—Alimentary Tract

Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitis

Review

Inflammation and fibrogenesis in steatohepatitis

Original Article—Alimentary Tract

Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits